SEC Form 4 · accession 0001553878-15-000034
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip A Sharp
Director
Period of report
Dec 4, 2015
Accepted (ET)
Dec 4, 2015 · 6:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 4, 2015 | M | 10,000 | $14.74 | A | 150,795 | D | |
| Common Stock | Dec 4, 2015 | M | 20,000 | $14.05 | A | 170,795 | D | |
| Common Stock | Dec 4, 2015 | S | 30,000 | $109.00 | D | 140,795 | D | |
| Common StockF2 | holding | — | — | — | 126,104 | I | by Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $14.05 | Dec 4, 2015 | M | 20,000 | D | Sep 2, 2007 | Sep 12, 2016 | Common Stock | 20,000 | 0 | D |
| Stock Option (right to buy) | $14.74 | Dec 4, 2015 | M | 10,000 | D | Jun 1, 2007 | Jun 1, 2016 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 30, 2015.
- F2The 126,104 shares reported as indirectly owned by trust include: (i) 94,838 shares in the Phillip A. Sharp 2009 Grantor Annuity Trust No. 3, and (ii) 31,266 shares in the Phillip A. Sharp 2008 Grantor Annuity Trust No. 2 (which include shares distributed from the 2010 Trust).